EMERGENT BIOSOLUTIONS INC. (EBS) Free cash flow 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$156.8MFY2025 · since FY2016: -$21.6M → $156.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $156.8M | +338.0% |
| FY2024 | $35.8M | +113.9% |
| FY2023 | -$257.9M | -72.0% |
| FY2022 | -$149.9M | -256.0% |
| FY2021 | $96.1M | -75.7% |
| FY2020 | $395.0M | +290.7% |
| FY2019 | $101.1M | +433.7% |
| FY2018 | -$30.3M | -119.8% |
| FY2017 | $153.3M | +809.7% |
| FY2016 | -$21.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice